Trusted Resources: Evidence & Education
Scientific literature and patient education texts
“Pain Is Subjective”: A Mixed-Method Study of Provider Attitudes and Practices Regarding Pain Management in Sickle Cell Disease Across Three Countries
source: Journal of Pain and Symptom Management
year: 2020
authors: Kearsley A.Stewart, Monika Parshad-Asnani, Ambroise Wonkam, John Bollinger, Valentina Ngo Bitoungui, Edmond Wonkam Tingang, Jill Powell, Kathia Desronvil, Kathryn Benson, Abby Clark, Madelaine Katz, Bianca Martin, Carolyn Peterseim, Christina Williams Nana Young, Nirmish Shah, Michael Babyak, Paula Tanabe, Charmaine DM.Royal
summary/abstract:Sickle cell disease (SCD), an autosomal recessive blood disorder, affects millions of people worldwide. Approximately 80% of all cases are located in Africa.
Objectives:
This cross-national, interdisciplinary, collaborative study investigated provider attitudes about, and practices for, managing (assessing and treating) SCD pain
Methods:
We conducted 111 quantitative surveys and 52 semi-structured interviews with healthcare providers caring for adults and/or children with SCD in Cameroon, Jamaica, and the United States (US)
Results:
Applying Haywood’s scale for assessing SCD provider attitudes, the Jamaica site scored lower on ‘Negative Attitudes’ than the Cameroonian and US sites (p =.03 and < .001, respectively). Providers at the US site scored lower on ‘Positive Attitudes’ than other sites (p <. 001). ‘Red Flag’ scores at the Cameroon sites were lower than at other sites (p < .001). Qualitative results across all three sites describe the current practices for SCD pain management, as well as the challenges surrounding management for health providers, including pain subjectivity, patient-provider and parent-provider relationships, resource availability, perceptions of drug-seeking behavior, and adherence. Providers also spontaneously offered solutions to reported challenges
Conclusion:
Overall, findings reveal that SCD provider attitudes toward their patients differed across sites, yet at all three sites, treating SCD pain is multidimensional.
DOI: 10.1016/j.jpainsymman.2020.08.029
read more
Related Content
-
Use of Marijuana in Patients with Sickle Cell Disease Increased the Frequency of Hospitalization for Acute Painful V...Introduction: Recently, there has been g...
-
CIRM and NHLBI Collaborating to Fund Cell and Gene Therapies for Sickle Cell DiseaseThe California Institute for Regenerativ...
-
Bioverativ and Bicycle Therapeutics Enter into Strategic Research Collaboration to Develop Therapies for Hemophilia ...Bioverativ Inc. (NASDAQ: BIVV), a global...
-
Review Board Finds Global Blood’s Sickle Cell Disease Therapy Voxelotor Is SafeAn independent review board has found Gl...
-
Successful Gene Therapy for Sickle Cell DiseasePrior to this report, the only curative ...
-
Stem cell gene-editing method may be breakthrough for sickle cell researchResearchers have cured mice with a genet...
-
Effects of Rifaximin on Circulating Aged Neutrophils in Sickle Cell DiseaseThere is a large therapeutic gap in sick...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.